Results 41 to 50 of about 438,911 (213)

Thoracic Stent Graft Implantation for Aortic Coarctation with Patent Ductus Arteriosus via Retroperitoneal Iliac Approach in the Presence of Small Sized Femoral Artery

open access: yesCase Reports in Cardiology, 2016
Endovascular stent graft implantation is a favorable method for complex aortic coarctation accompanied by patent ductus arteriosus. Herein, an 18-year-old woman with complex aortic coarctation and patent ductus arteriosus was successfully treated by ...
Ozge Korkmaz   +4 more
doaj   +1 more source

Morphology of the patent arterial duct : features relevant to treatment [PDF]

open access: yes, 2008
Patent ductus arteriosus (PDA), one of the most common congenital heart defects, is an abnormal persistence of a patent lumen in the arterial duct due to an arrest of the natural process of closure after it has served its function as a vital channel ...
Ho, Siew Yen   +2 more
core  

Prevalence of patent ductus arteriosus.

open access: yes, 2013
Prevalence of patent ductus arteriosus.
Feng Zhao (90241)   +3 more
core   +1 more source

Subaortic membrane with patent ductus arteriosus [PDF]

open access: yes, 2017
A 10 years old boy diagnosed as subaortic membrane with patent ductus arteriosus presented with history of occasional fever, repeated respiratory tract infection since childhood and poor gain ...
Alka Singh   +4 more
core   +1 more source

Heterozygous Variants in LRP1 Cause a Neurodevelopmental Disorder With Congenital Heart Defects

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT LRP1 encodes the low‐density lipoprotein (LDL) receptor‐related protein 1 (LRP1), a transmembrane protein involved in endocytosis and activation of multiple signaling pathways. LRP1 variants have been implicated in the pathogenesis of congenital heart defects (CHD), Alzheimer's disease, and neurodevelopmental disorders (NDD).
Alyssa L. Rippert   +31 more
wiley   +1 more source

Ductal closure with radiofrequency energy; outcomes of the first series

open access: yesIndian Heart Journal, 2020
Using radiofrequency energy for closure of the patent ductus arteriosus (PDA) has been reported by us previously. In this article we report the early and late outcome of the first group in whom patent ductus arteriosus has been occluded with ...
Mohammad Dalili   +2 more
doaj   +1 more source

Patent ductus arteriosus as rare cause of sudden death. Case report of a 4-day-old infant [PDF]

open access: yes, 2015
Ein persistierender Ductus arteriosus (Ductus Botalli) ist seit Jahren als Ursache eines plötzlichen und unerwarteten Neugeborenentods und pulmonaler Hämorrhagien identifiziert.
Albalooshi, Y.   +3 more
core   +1 more source

Systematic Cardiac Phenotyping of Patients With Copy Number Variants in the 15q11.2 Breakpoint 1 to Breakpoint 2 Region: A Retrospective Cohort Study From Nine Pediatric Cardiac Centers

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Microdeletions impacting 15q11.2 breakpoint (BP) 1 to BP2, adjacent to the Prader–Willi critical region, have previously described neuropsychiatric associations, with potential low penetrance presentations of congenital heart disease (CHD) also identified.
Morgan B. Wright   +10 more
wiley   +1 more source

Anatomical Characteristics of Patent Ductus Arteriosus and Choice of Transcatheter Occluder Devices

open access: yesPakistan Armed Forces Medical Journal
Objective: To determine the anatomical characteristics of Patent Ductus Arteriosus, choice of transcatheter occluder device and outcomes of Patent Ductus Arteriosus device closure. Study Design: Analytical Cross-sectional study.
Saima Rafique   +7 more
doaj   +1 more source

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

open access: yesFrontiers in Pediatrics, 2020
Background: Indomethacin and ibuprofen, two commonly used prostaglandin inhibitors, are the drugs of choice for patent ductus arteriosus. However, paracetamol is an alternative choice when these drugs are ineffective or contraindicated.
Yingqi Xiao   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy